These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22164651)

  • 1. Genetic diseases: is there a duty to a patient's family members?
    Sutton M; Elliott RL
    J Med Assoc Ga; 2011; 100(3):28-9. PubMed ID: 22164651
    [No Abstract]   [Full Text] [Related]  

  • 2. Mother still knows best: cancer-related gene mutations, familial privacy, and a physician's duty to warn.
    Brownrigg A
    Fordham Urban Law J; 1999 Jan; 26(2):247-79. PubMed ID: 16437785
    [No Abstract]   [Full Text] [Related]  

  • 3. Genomic torts: the law of the future--the duty of physicians to disclose the presence of a genetic disease to the relatives of their patients with the disease.
    Deftos LJ
    Spec Law Dig Health Care Law; 1998 Sep; (234):9-41. PubMed ID: 10185166
    [No Abstract]   [Full Text] [Related]  

  • 4. The "duty to warn" a patient's family members about hereditary disease risks.
    Offit K; Groeger E; Turner S; Wadsworth EA; Weiser MA
    JAMA; 2004 Sep; 292(12):1469-73. PubMed ID: 15383518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A physician's duty to warn family members of genetic risks: limiting the importance of Tarasoff.
    Russell S
    J Biolaw Bus; 2003; 6(1):28-38. PubMed ID: 15239180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should doctors have a legal duty to warn relatives of their genetic risks?
    Middleton A; Milne R; Robarts L; Roberts J; Patch C
    Lancet; 2019 Dec; 394(10215):2133-2135. PubMed ID: 31784025
    [No Abstract]   [Full Text] [Related]  

  • 7. Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid.
    Dyer C
    BMJ; 2012 Dec; 345():e8266. PubMed ID: 23223689
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic testing: do healthcare professionals have a duty to tell a patient's family members that they may be at risk?
    Marta MR
    J Healthc Risk Manag; 1999; 19(3):26-38. PubMed ID: 10538434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of BRCA1 mutations in a Pakistani family with hereditary breast and ovarian cancer syndrome.
    Moslehi R; Solehdin F; Malik I; Narod S
    Am J Med Genet; 1998 Jul; 78(4):386-7. PubMed ID: 9714446
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Camping trips and family trees: must Tennessee physicians warn their patients' relatives of genetic risks?
    Parker CM
    Tenn Law Rev; 1998; 65(2):585-618. PubMed ID: 11863017
    [No Abstract]   [Full Text] [Related]  

  • 12. Cascade screening: whose information is it anyway?
    de Wert G
    Eur J Hum Genet; 2005 Apr; 13(4):397-8. PubMed ID: 15702129
    [No Abstract]   [Full Text] [Related]  

  • 13. The Double Helix: Applying an Ethic of Care to the Duty to Warn Genetic Relatives of Genetic Information.
    Weaver M
    Bioethics; 2016 Mar; 30(3):181-7. PubMed ID: 26194147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
    Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
    J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To tell or not to tell: the scope of physician-patient confidentiality when relatives are at risk of genetic disease.
    Sudell A
    J Contemp Health Law Policy; 2001; 18(1):273-95. PubMed ID: 15255062
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on the Manchester Scoring System for BRCA1 and BRCA2 testing.
    Evans DG; Lalloo F; Wallace A; Rahman N
    J Med Genet; 2005 Jul; 42(7):e39. PubMed ID: 15994864
    [No Abstract]   [Full Text] [Related]  

  • 17. Duty to warn of genetic harm in breach of patient confidentiality.
    Keeling SL
    J Law Med; 2004 Nov; 12(2):235-53. PubMed ID: 15575325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene patenting--is the pendulum swinging back?
    Kesselheim AS; Mello MM
    N Engl J Med; 2010 May; 362(20):1855-8. PubMed ID: 20375396
    [No Abstract]   [Full Text] [Related]  

  • 19. Should researchers disclose results to descendants?
    Rothstein MA
    Am J Bioeth; 2013; 13(10):64-5. PubMed ID: 24024818
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
    James PA; Harris M; Lindeman GJ; Mitchell G
    J Med Genet; 2008 Nov; 45(11):765-6. PubMed ID: 18978334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.